ArticleBMC cancer2022
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression.
Qi Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBMC cancer2022
Qi Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.